Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Performance of the Epi proColon and Fecal ImmunochemicalTest Post Colonoscopy in Subjects With Colorectal Cancer and Pre Colonoscopy in Subjects From a Guideline-Eligible Screening Population

NCT01580540 is registered in ClinicalTrials.gov with Epigenomics, Inc as lead sponsor.

NCT NCT01580540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01580540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Performance of the Epi proColon and Fecal ImmunochemicalTest Post Colonoscopy in Subjects With Colorectal Cancer and Pre Colonoscopy in Subjects From a Guideline-Eligible Screening Population
Lead sponsor
Epigenomics, Inc
Phase
Observational
Overall status
Completed
Start date
March 31, 2012
Completion date
November 30, 2012
Enrollment
336 (actual)
Sites
70

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer